EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The role of combined multichannel intraluminal impedance and pH-monitoring in newborn with gastroesophageal reflux disease

Francesco Cresi, Emanuela Locatelli

Reviews in Health Care · 2010

DOI: 10.7175/rhc.v1i1.16 ↗
AbstractBibliografische Angaben

Abstract

Gastroesophageal reflux disease (GERD) is a relevant problem in first months of life and its early diagnosis and its appropriate therapy represent a real challenge for neonatologists.Multichannel Intraluminal Impedance associated with esophageal pH-monitoring (MII/pH) has been recently introduced to study GERD in infants. This technique, which is safe and with a good compliance, presents an elevated accuracy in identifying refluxes independently from their pH. The main aim of this review is to analyse data in literature on the use of MII/pH in neonates.We have considered recent studies published in PubMed in which MII is used in neonates and infants with GER: 26 studies focus on GER physiopathology and on the advantages of using MII in addition to pH-monitoring, 13 on symptoms associated with refluxes (in particular cardio-respiratory events and apnoeas) and 13 on therapy (5 on body position, 3 on thickened formulas, 1 on fortified milk and 4 on drugs).We underline the role of MII/pH in studying GERD in neonates, in which non acid-refluxes result prevalent, because of the buffering effects of milk, and in which the majority of symptoms arerelated to non-acid or weakly-acid GER. MII/pH can be considered a good technique even in the evaluation of the temporal relation between refluxes and symptoms and in the analysis of the benefits obtained by pharmacological and non-pharmacological therapy.The increasing application of MII/pH can help neonatologists to comprehend GER physiopathology, to diagnose GER and GERD and to treat better its symptoms in first months of life.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →